Canadian Summary:
During week 52, localized influenza activity was reported in one
health region in British Columbia and one health region in Ontario
(Toronto). Sporadic activity was reported in parts of Yukon,
British Columbia, Alberta, Ontario and Quebec, while the rest of
the country reported no activity. Over the one week period, the
Public Health Agency of Canada received 1612 reports of laboratory
tests for influenza, with 43 influenza A and 30 influenza B
detections. Most of the influenza A detections (70%) were in
British Columbia and most of the influenza B detections (97%) were
in Alberta (see table below).
Influenza-like Illness (ILI):
ILI consultation rate was calculated as 29 per 1000 patient visits
in week 52, which is below the expected range for this week
(see ILI graph).
Outbreaks:
During week 52, 2 new LTCF
outbreaks were reported (Ontario & British Columbia). To date
this season, 8 LTCF outbreaks have been reported (1 each in
Ontario, Manitoba & Saskatchewan, and 5 in British
Columbia).
Antigenic Characterization:
Since the start of the 2005-2006 influenza season, the National
Microbiology Laboratory (NML) has antigenically characterized 39
influenza viruses; 20 A/California/07/2004(H3N2)-like viruses (12
in British Columbia, 3 in Saskatchewan and 5 in Ontario), 16 B/Hong
Kong/330/2001-like viruses (1 in the Yukon,1 in British Columbia
& 14 in Alberta) belonging to the B/Victoria/2/1987 lineage,
and 3 B/Shanghai/361/2002-like viruses (British Columbia, Alberta
& Ontario ) belonging to the B/Yamagata/16/1988 lineage.
* The 2005-2006 season Canadian vaccine contains an A/New Caledonia/20/1999(H1N1)-like, an A/California/7/2004(H3N2)-like, and a B/Shanghai/361/2002-like virus strain.
Vaccine Match:
To date, 100% (20) of the influenza A strains
(A/California/07/2004(H3N2)-like viruses) characterized by the NML
have matched the A/H3N2 strain included in the 2005-2006 Canadian
vaccine. However, only 16% (3/19) of the influenza B
characterizations have matched the vaccine strain
(B/Shanghai/361/2002-like viruses). The remaining 84% (16/19) of
the influenza B strains characterized by the NML have been B/Hong
Kong/330/2001-like viruses, which belong to a separate lineage of
viruses not covered by this year's vaccine. Most of the
identifications of B/Hong Kong/330/2001-like viruses have been
associated with school outbreaks in Alberta. No influenza A/H1N1
viruses have been identified to date.
Influenza-associated Pediatric
Hospitalizations:
During week 52, 3 laboratory-confirmed influenza-associated
hospitalizations (in British Columbia) were reported through the
IMPACT (Immunization Monitoring Program ACTive) network. All were
due to influenza A. Fourteen cases (1 in Ontario, 1 in Alberta
& 12 in British Columbia) have been reported to IMPACT since
the start of this influenza season.
United States: CDC
During week 51, influenza activity continued to increase in the
western United States. The proportion of patient visits to sentinel
providers for ILI (3.1%) was above the national baseline, while the
proportion of deaths due to pneumonia and influenza (7.0%) remains
below baseline levels. Since 2 October 2005, CDC has received
reports of five influenza-associated pediatric deaths, one of which
occurred in week 51. Since 1 October 2005, the CDC has
antigenically characterized 26 influenza viruses: 21
A/California/07/2004(H3N2)-like viruses, 2 H3N2 showing reduced
titers with antisera produced against
A/California/07/2004(H3N2)-like viruses, 2
B/Yamagata/16/1988-lineage viruses and 1 B/Victoria/2/1987-lineage
virus.
International:
EISS: In week 52, clinical influenza activity in
Europe remains at baseline levels. The total number of weekly
influenza virus detections remains low: 54% were influenza A and
46% were influenza B.
Human Avian Influenza:
During week 01/2006, the WHO reported the first 2 human cases with
avian influenza (H5N1) infection in Turkey. Both cases were fatal.
The first case was a 14-year-old boy who was hospitalized on 1
January 2006 and died the same day. The second case was his
15-year-old sister who was also hospitalized on 1 January 2006 and
died on 5 January 2006. These 2 cases mark the first confirmed
reports of human infection with avian influenza outside East
Asia.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Specimens from NT, YT, and NU are sent to reference laboratories in other provinces.
Note: Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals.
Abbreviations: Newfoundland/Labrador (NL), Prince Edward Island (PE), New Brunswick (NB), Nova Scotia (NS), Quebec (QC), Ontario (ON), Manitoba (MB), Saskatchewan (SK), Alberta (AB), British Columbia (BC), Yukon (YT), Northwest Territories (NT), Nunavut (NU)
Respiratory virus laboratory detections in Canada, by
geographic regions, are available weekly on the following
website:
<http://www.phac-aspc.gc.ca/bid-bmi/dsd-dsm/rvdi-divr/index-eng.php>


† sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.
Influenza Activity
Level by Provincial and Territorial |
||||||||||||
|
||||||||||||
Note: Influenza activity levels, as represented
on this map, are assigned and reported by Provincial and
Territorial Ministries of Health, based on laboratory
confirmations, sentinel ILI rates (see graphs and tables) and outbreaks. Please refer to detailed definitions for the 2005-2006
season. For areas where no data is reported, late reports from
these provinces and territories will appear on the FluWatch website. Select single maps by report week to get
this updated information. Click on the map to view provinces/territories and maps for other weeks. |
||||||||||||





(Strain characterization, number identified, per cent of total number)
NACI recommends that the trivalent vaccine for the 2005-2006 season in Canada contain A/New Caledonia/20/99 (H1N1)-like, A/California/7/2004 (H3N2)-like, and B/Shanghai/361/2002-like virus antigens.
* The B/Shanghai/361/2002-like virus belongs to the B/Yamagata/16/88 lineage; the B/Hong Kong/330/01-like virus belongs to the B/Victoria/02/87 lineage which is not covered by this year's vaccine.


Note: No data available for mean rate in previous years for weeks 21 to 39 (1996-1997 through 2002-2003 seasons). During weeks 20-39, 2002-2003/2004-2005 seasons, ILI is reported once every two weeks, on even weeks only


Please note that the above graphs may change as
late returns come in.
Single Maps | Dual Maps | Animated Maps | FluWatch Reports
Definitions for the 2005-2006 season
To share this page just click on the social network icon of your choice.